Clinical Trials on Sphb Haemoglobin in Vivo Validation in Canada
Total 1 results
-
University of British ColumbiaMasimo CorporationCompletedHemoglobin Levels in BloodCanada
Sponsors and Collaborators
- InflaRx GmbH
- Bruce County Paramedic Service
- Veeda Oncology
- BayCare Health System
- Neuregenix
- Centro di Procreazione Assistita Demetra
- Nestor Soler Porcar, MD, PhD
- Chengdu Nuoen Biotechnologies, Inc.
- AIDS Council of New South Wales
- Grand Challenges Canada
- ImproveCareNow (ICN)
- Yantai Yuhuangding Hospital，Medical College, Qingdao University
- Mononuclear Therapeutics Ltd.
- Reina Sofia University Hospital
- Prestige Biopharma Limited
- Equipe MiMes
- Maria Lendorf
- Bjørgene Omsorgssenter, Haugesund
- Women and children's hospital of Jiaxing university
- North Karelia Hospital District
- View Full List
Medical Conditions
- Ewing's Family Tumors
- Multisystem Proteinopathy
- Painless Hysteroscopy
- Predictors of Atrial Fibrillation Recurrences
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Endocarditis Infective
- Pulmonary Adenocarcinoma
- Chlamydophila Infections
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Skull Base Neoplasms
- Psoriasis, Arthritic
- Childhood Langerhans Cell Histiocytosis
- Fetus or Neonate Affected by External Version Before Labor
- Fracture Dislocation of Cervical Spine
- Tay-Sachs Disease Ganglioside
- Closure; Foramen Ovale
- Spine Surgeries
- Gullian Barre Syndrome
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Epidemic Hemorrhagic Fever
- View Full List
Drug Interventions
- High dose pantoprazole infusion
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Cereport
- Redifferentiation with retinoid acid
- Adriamycin
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Glimepiride
- Chemotherapeutic Agent
- Estradiol+Drospirenone
- Azelastine hydrochloride (BAYR9258)
- Palliative care group first-line scheme
- Esomeprazole 40mg before
- Adapalene Gel 0.3%
- Neihulizumab
- Semapimod
- Qingkailing injection 40 ml
- Vehicle
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- EFV +TVA
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Angola
- Contract Research Organizations in Canada
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Denmark
- Contract Research Organizations in Estonia
- Contract Research Organizations in Georgia
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Moldova
- Contract Research Organizations in Mongolia
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Peru
- Contract Research Organizations in Qatar
- CRO list by country